Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $1.2 million.

  • Tonix Pharmaceuticals Holding's Interest & Investment Income rose 673888.89% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 100757.58%. This contributed to the annual value of $1.7 million for FY2023, which is 806.19% down from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Interest & Investment Income of $1.2 million as of Q3 2025, which was up 673888.89% from $943000.0 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Interest & Investment Income peaked at $1.2 million during Q3 2025, and registered a low of $1000.0 during Q2 2024.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Interest & Investment Income averaged around $395333.3, with its median value being $95000.0 (2023).
  • In the last 5 years, Tonix Pharmaceuticals Holding's Interest & Investment Income tumbled by 8953.49% in 2024 and then surged by 9420000.0% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Interest & Investment Income stood at $7000.0 in 2023, then surged by 157.14% to $18000.0 in 2024, then skyrocketed by 6738.89% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $943000.0 for Q2 2025, and $18000.0 during Q3 2024.